Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04971785 |
|---|---|
| Brief Title: | Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (WAYFIND) |
| First Submitted : | July 20, 2021 |
| First Submitted that Met QC Criteria : | July 20, 2021 |
| First Posted : | July 21, 2021 |
| Last Update Submitted that Met QC Criteria : | February 26, 2024 |
| Last Update Posted : | February 28, 2024 |